1. Home
  2. HALO vs EAT Comparison

HALO vs EAT Comparison

Compare HALO & EAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • EAT
  • Stock Information
  • Founded
  • HALO 1998
  • EAT 1975
  • Country
  • HALO United States
  • EAT United States
  • Employees
  • HALO N/A
  • EAT N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • EAT Restaurants
  • Sector
  • HALO Health Care
  • EAT Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • EAT Nasdaq
  • Market Cap
  • HALO 7.4B
  • EAT 6.2B
  • IPO Year
  • HALO N/A
  • EAT N/A
  • Fundamental
  • Price
  • HALO $58.79
  • EAT $153.45
  • Analyst Decision
  • HALO Buy
  • EAT Hold
  • Analyst Count
  • HALO 9
  • EAT 17
  • Target Price
  • HALO $61.63
  • EAT $141.93
  • AVG Volume (30 Days)
  • HALO 1.8M
  • EAT 1.5M
  • Earning Date
  • HALO 05-06-2025
  • EAT 04-29-2025
  • Dividend Yield
  • HALO N/A
  • EAT N/A
  • EPS Growth
  • HALO 63.33
  • EAT 69.43
  • EPS
  • HALO 3.43
  • EAT 5.73
  • Revenue
  • HALO $1,015,324,000.00
  • EAT $4,825,700,000.00
  • Revenue This Year
  • HALO $20.06
  • EAT $19.63
  • Revenue Next Year
  • HALO $24.04
  • EAT $4.75
  • P/E Ratio
  • HALO $17.14
  • EAT $26.80
  • Revenue Growth
  • HALO 22.44
  • EAT 13.67
  • 52 Week Low
  • HALO $37.73
  • EAT $43.37
  • 52 Week High
  • HALO $66.00
  • EAT $192.22
  • Technical
  • Relative Strength Index (RSI)
  • HALO 44.06
  • EAT 55.46
  • Support Level
  • HALO $57.50
  • EAT $147.38
  • Resistance Level
  • HALO $62.14
  • EAT $154.72
  • Average True Range (ATR)
  • HALO 2.90
  • EAT 10.73
  • MACD
  • HALO -0.40
  • EAT 1.33
  • Stochastic Oscillator
  • HALO 36.41
  • EAT 93.28

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About EAT Brinker International Inc.

Brinker International Inc operates casual dining restaurants under the brand's Chili Grill and Bar (Chili's) and Maggiano's Little Italy (Maggiano's). Chili's falls in the Bar and Grill category of casual dining. Its menu features Fresh Mex and Fresh Tex favorites including signature items such as slow-smoked baby back ribs, craft burgers, fajitas, and bottomless chips and salsa paired with tableside guacamole. Maggiano's is an Italian restaurant brand with a full lunch and dinner menu offering chef-prepared, such as appetizers, chicken, seafood, veal and prime steaks, and desserts. The company generates maximum revenue from Chili's segment.

Share on Social Networks: